1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Beta-lactams Drugs
        1.2.3 Carbapenems Drugs
        1.2.4 Fluoroquinolones Drugs
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Enterobacteriaceae Infection Drug Market Perspective (2017-2028)
    2.2 Enterobacteriaceae Infection Drug Growth Trends by Region
        2.2.1 Enterobacteriaceae Infection Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Enterobacteriaceae Infection Drug Historic Market Size by Region (2017-2022)
        2.2.3 Enterobacteriaceae Infection Drug Forecasted Market Size by Region (2023-2028)
    2.3 Enterobacteriaceae Infection Drug Market Dynamics
        2.3.1 Enterobacteriaceae Infection Drug Industry Trends
        2.3.2 Enterobacteriaceae Infection Drug Market Drivers
        2.3.3 Enterobacteriaceae Infection Drug Market Challenges
        2.3.4 Enterobacteriaceae Infection Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Enterobacteriaceae Infection Drug Players by Revenue
        3.1.1 Global Top Enterobacteriaceae Infection Drug Players by Revenue (2017-2022)
        3.1.2 Global Enterobacteriaceae Infection Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Enterobacteriaceae Infection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Enterobacteriaceae Infection Drug Revenue
    3.4 Global Enterobacteriaceae Infection Drug Market Concentration Ratio
        3.4.1 Global Enterobacteriaceae Infection Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Enterobacteriaceae Infection Drug Revenue in 2021
    3.5 Enterobacteriaceae Infection Drug Key Players Head office and Area Served
    3.6 Key Players Enterobacteriaceae Infection Drug Product Solution and Service
    3.7 Date of Enter into Enterobacteriaceae Infection Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Enterobacteriaceae Infection Drug Breakdown Data by Type
    4.1 Global Enterobacteriaceae Infection Drug Historic Market Size by Type (2017-2022)
    4.2 Global Enterobacteriaceae Infection Drug Forecasted Market Size by Type (2023-2028)
5 Enterobacteriaceae Infection Drug Breakdown Data by Application
    5.1 Global Enterobacteriaceae Infection Drug Historic Market Size by Application (2017-2022)
    5.2 Global Enterobacteriaceae Infection Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Enterobacteriaceae Infection Drug Market Size (2017-2028)
    6.2 North America Enterobacteriaceae Infection Drug Market Size by Type
        6.2.1 North America Enterobacteriaceae Infection Drug Market Size by Type (2017-2022)
        6.2.2 North America Enterobacteriaceae Infection Drug Market Size by Type (2023-2028)
        6.2.3 North America Enterobacteriaceae Infection Drug Market Share by Type (2017-2028)
    6.3 North America Enterobacteriaceae Infection Drug Market Size by Application
        6.3.1 North America Enterobacteriaceae Infection Drug Market Size by Application (2017-2022)
        6.3.2 North America Enterobacteriaceae Infection Drug Market Size by Application (2023-2028)
        6.3.3 North America Enterobacteriaceae Infection Drug Market Share by Application (2017-2028)
    6.4 North America Enterobacteriaceae Infection Drug Market Size by Country
        6.4.1 North America Enterobacteriaceae Infection Drug Market Size by Country (2017-2022)
        6.4.2 North America Enterobacteriaceae Infection Drug Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Enterobacteriaceae Infection Drug Market Size (2017-2028)
    7.2 Europe Enterobacteriaceae Infection Drug Market Size by Type
        7.2.1 Europe Enterobacteriaceae Infection Drug Market Size by Type (2017-2022)
        7.2.2 Europe Enterobacteriaceae Infection Drug Market Size by Type (2023-2028)
        7.2.3 Europe Enterobacteriaceae Infection Drug Market Share by Type (2017-2028)
    7.3 Europe Enterobacteriaceae Infection Drug Market Size by Application
        7.3.1 Europe Enterobacteriaceae Infection Drug Market Size by Application (2017-2022)
        7.3.2 Europe Enterobacteriaceae Infection Drug Market Size by Application (2023-2028)
        7.3.3 Europe Enterobacteriaceae Infection Drug Market Share by Application (2017-2028)
    7.4 Europe Enterobacteriaceae Infection Drug Market Size by Country
        7.4.1 Europe Enterobacteriaceae Infection Drug Market Size by Country (2017-2022)
        7.4.2 Europe Enterobacteriaceae Infection Drug Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size (2017-2028)
    8.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type
        8.2.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Enterobacteriaceae Infection Drug Market Share by Type (2017-2028)
    8.3 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application
        8.3.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Enterobacteriaceae Infection Drug Market Share by Application (2017-2028)
    8.4 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region
        8.4.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Enterobacteriaceae Infection Drug Market Size (2017-2028)
    9.2 Latin America Enterobacteriaceae Infection Drug Market Size by Type
        9.2.1 Latin America Enterobacteriaceae Infection Drug Market Size by Type (2017-2022)
        9.2.2 Latin America Enterobacteriaceae Infection Drug Market Size by Type (2023-2028)
        9.2.3 Latin America Enterobacteriaceae Infection Drug Market Share by Type (2017-2028)
    9.3 Latin America Enterobacteriaceae Infection Drug Market Size by Application
        9.3.1 Latin America Enterobacteriaceae Infection Drug Market Size by Application (2017-2022)
        9.3.2 Latin America Enterobacteriaceae Infection Drug Market Size by Application (2023-2028)
        9.3.3 Latin America Enterobacteriaceae Infection Drug Market Share by Application (2017-2028)
    9.4 Latin America Enterobacteriaceae Infection Drug Market Size by Country
        9.4.1 Latin America Enterobacteriaceae Infection Drug Market Size by Country (2017-2022)
        9.4.2 Latin America Enterobacteriaceae Infection Drug Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size (2017-2028)
    10.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type
        10.2.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Share by Type (2017-2028)
    10.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application
        10.3.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Share by Application (2017-2028)
    10.4 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country
        10.4.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Genentech
        11.1.1 Genentech Company Details
        11.1.2 Genentech Business Overview
        11.1.3 Genentech Enterobacteriaceae Infection Drug Introduction
        11.1.4 Genentech Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.1.5 Genentech Recent Developments
    11.2 Nanotherapeutics
        11.2.1 Nanotherapeutics Company Details
        11.2.2 Nanotherapeutics Business Overview
        11.2.3 Nanotherapeutics Enterobacteriaceae Infection Drug Introduction
        11.2.4 Nanotherapeutics Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.2.5 Nanotherapeutics Recent Developments
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Enterobacteriaceae Infection Drug Introduction
        11.3.4 Novartis Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.3.5 Novartis Recent Developments
    11.4 Pfizer
        11.4.1 Pfizer Company Details
        11.4.2 Pfizer Business Overview
        11.4.3 Pfizer Enterobacteriaceae Infection Drug Introduction
        11.4.4 Pfizer Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.4.5 Pfizer Recent Developments
    11.5 Nymox Pharmaceutical
        11.5.1 Nymox Pharmaceutical Company Details
        11.5.2 Nymox Pharmaceutical Business Overview
        11.5.3 Nymox Pharmaceutical Enterobacteriaceae Infection Drug Introduction
        11.5.4 Nymox Pharmaceutical Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.5.5 Nymox Pharmaceutical Recent Developments
    11.6 Sequoia Sciences
        11.6.1 Sequoia Sciences Company Details
        11.6.2 Sequoia Sciences Business Overview
        11.6.3 Sequoia Sciences Enterobacteriaceae Infection Drug Introduction
        11.6.4 Sequoia Sciences Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.6.5 Sequoia Sciences Recent Developments
    11.7 Phico Therapeutics
        11.7.1 Phico Therapeutics Company Details
        11.7.2 Phico Therapeutics Business Overview
        11.7.3 Phico Therapeutics Enterobacteriaceae Infection Drug Introduction
        11.7.4 Phico Therapeutics Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.7.5 Phico Therapeutics Recent Developments
    11.8 Cantab Biopharmaceuticals
        11.8.1 Cantab Biopharmaceuticals Company Details
        11.8.2 Cantab Biopharmaceuticals Business Overview
        11.8.3 Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Introduction
        11.8.4 Cantab Biopharmaceuticals Revenue in Enterobacteriaceae Infection Drug Business (2017-2022)
        11.8.5 Cantab Biopharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Beta-lactams Drugs
    Table 3. Key Players of Carbapenems Drugs
    Table 4. Key Players of Fluoroquinolones Drugs
    Table 5. Key Players of Others
    Table 6. Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Enterobacteriaceae Infection Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Enterobacteriaceae Infection Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Enterobacteriaceae Infection Drug Market Share by Region (2017-2022)
    Table 10. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Enterobacteriaceae Infection Drug Market Share by Region (2023-2028)
    Table 12. Enterobacteriaceae Infection Drug Market Trends
    Table 13. Enterobacteriaceae Infection Drug Market Drivers
    Table 14. Enterobacteriaceae Infection Drug Market Challenges
    Table 15. Enterobacteriaceae Infection Drug Market Restraints
    Table 16. Global Enterobacteriaceae Infection Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Enterobacteriaceae Infection Drug Revenue Share by Players (2017-2022)
    Table 18. Global Top Enterobacteriaceae Infection Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterobacteriaceae Infection Drug as of 2021)
    Table 19. Ranking of Global Top Enterobacteriaceae Infection Drug Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Enterobacteriaceae Infection Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Enterobacteriaceae Infection Drug Product Solution and Service
    Table 23. Date of Enter into Enterobacteriaceae Infection Drug Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Enterobacteriaceae Infection Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2017-2022)
    Table 27. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2023-2028)
    Table 29. Global Enterobacteriaceae Infection Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Enterobacteriaceae Infection Drug Revenue Share by Application (2017-2022)
    Table 31. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Enterobacteriaceae Infection Drug Revenue Share by Application (2023-2028)
    Table 33. North America Enterobacteriaceae Infection Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Enterobacteriaceae Infection Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Enterobacteriaceae Infection Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Enterobacteriaceae Infection Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Enterobacteriaceae Infection Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Enterobacteriaceae Infection Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Enterobacteriaceae Infection Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Enterobacteriaceae Infection Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Enterobacteriaceae Infection Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Enterobacteriaceae Infection Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Enterobacteriaceae Infection Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Enterobacteriaceae Infection Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Enterobacteriaceae Infection Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Enterobacteriaceae Infection Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Enterobacteriaceae Infection Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Enterobacteriaceae Infection Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Enterobacteriaceae Infection Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Enterobacteriaceae Infection Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Enterobacteriaceae Infection Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Enterobacteriaceae Infection Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Enterobacteriaceae Infection Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Enterobacteriaceae Infection Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Enterobacteriaceae Infection Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Genentech Company Details
    Table 64. Genentech Business Overview
    Table 65. Genentech Enterobacteriaceae Infection Drug Product
    Table 66. Genentech Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 67. Genentech Recent Developments
    Table 68. Nanotherapeutics Company Details
    Table 69. Nanotherapeutics Business Overview
    Table 70. Nanotherapeutics Enterobacteriaceae Infection Drug Product
    Table 71. Nanotherapeutics Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 72. Nanotherapeutics Recent Developments
    Table 73. Novartis Company Details
    Table 74. Novartis Business Overview
    Table 75. Novartis Enterobacteriaceae Infection Drug Product
    Table 76. Novartis Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 77. Novartis Recent Developments
    Table 78. Pfizer Company Details
    Table 79. Pfizer Business Overview
    Table 80. Pfizer Enterobacteriaceae Infection Drug Product
    Table 81. Pfizer Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 82. Pfizer Recent Developments
    Table 83. Nymox Pharmaceutical Company Details
    Table 84. Nymox Pharmaceutical Business Overview
    Table 85. Nymox Pharmaceutical Enterobacteriaceae Infection Drug Product
    Table 86. Nymox Pharmaceutical Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 87. Nymox Pharmaceutical Recent Developments
    Table 88. Sequoia Sciences Company Details
    Table 89. Sequoia Sciences Business Overview
    Table 90. Sequoia Sciences Enterobacteriaceae Infection Drug Product
    Table 91. Sequoia Sciences Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 92. Sequoia Sciences Recent Developments
    Table 93. Phico Therapeutics Company Details
    Table 94. Phico Therapeutics Business Overview
    Table 95. Phico Therapeutics Enterobacteriaceae Infection Drug Product
    Table 96. Phico Therapeutics Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 97. Phico Therapeutics Recent Developments
    Table 98. Cantab Biopharmaceuticals Company Details
    Table 99. Cantab Biopharmaceuticals Business Overview
    Table 100. Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Product
    Table 101. Cantab Biopharmaceuticals Revenue in Enterobacteriaceae Infection Drug Business (2017-2022) & (US$ Million)
    Table 102. Cantab Biopharmaceuticals Recent Developments
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Enterobacteriaceae Infection Drug Market Share by Type: 2021 VS 2028
    Figure 2. Beta-lactams Drugs Features
    Figure 3. Carbapenems Drugs Features
    Figure 4. Fluoroquinolones Drugs Features
    Figure 5. Others Features
    Figure 6. Global Enterobacteriaceae Infection Drug Market Share by Application: 2021 VS 2028
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Retail Pharmacies Case Studies
    Figure 9. Online Pharmacies Case Studies
    Figure 10. Enterobacteriaceae Infection Drug Report Years Considered
    Figure 11. Global Enterobacteriaceae Infection Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Enterobacteriaceae Infection Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Enterobacteriaceae Infection Drug Market Share by Region: 2021 VS 2028
    Figure 14. Global Enterobacteriaceae Infection Drug Market Share by Players in 2021
    Figure 15. Global Top Enterobacteriaceae Infection Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterobacteriaceae Infection Drug as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Enterobacteriaceae Infection Drug Revenue in 2021
    Figure 17. North America Enterobacteriaceae Infection Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Enterobacteriaceae Infection Drug Market Size Market Share by Type (2017-2028)
    Figure 19. North America Enterobacteriaceae Infection Drug Market Size Market Share by Application (2017-2028)
    Figure 20. North America Enterobacteriaceae Infection Drug Market Size Share by Country (2017-2028)
    Figure 21. United States Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Enterobacteriaceae Infection Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Enterobacteriaceae Infection Drug Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Enterobacteriaceae Infection Drug Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Enterobacteriaceae Infection Drug Market Size Share by Country (2017-2028)
    Figure 27. Germany Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Enterobacteriaceae Infection Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Enterobacteriaceae Infection Drug Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Enterobacteriaceae Infection Drug Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Enterobacteriaceae Infection Drug Market Size Share by Region (2017-2028)
    Figure 37. China Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Enterobacteriaceae Infection Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Enterobacteriaceae Infection Drug Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Enterobacteriaceae Infection Drug Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Enterobacteriaceae Infection Drug Market Size Share by Country (2017-2028)
    Figure 47. Mexico Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Enterobacteriaceae Infection Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Enterobacteriaceae Infection Drug Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Enterobacteriaceae Infection Drug Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Enterobacteriaceae Infection Drug Market Size Share by Country (2017-2028)
    Figure 53. Turkey Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Enterobacteriaceae Infection Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Genentech Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 57. Nanotherapeutics Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 58. Novartis Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 59. Pfizer Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 60. Nymox Pharmaceutical Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 61. Sequoia Sciences Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 62. Phico Therapeutics Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 63. Cantab Biopharmaceuticals Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed